|
 |
|
|
|||
|
 |
|
Jul. 9, 2018 Source: Bayer news release Bayer Animal Health GmbH and Mitsui Chemicals Agro, Inc. (MCAG) have signed a global license agreement to advance innovative parasiticides for companion animals based on MCAG's innovation and technology. As part of the license agreement, Bayer will develop and commercialize novel compounds based on intellectual property from MCAG. Further terms of the agreement were not disclosed. Pet ownership is growing around the world and with that customers' requirement for effective and convenient protection from parasites. "At Bayer, we passionately care for the health and well-being of animals," said Dr. Dirk Ehle, Head of Bayer Animal Health. "And we have long been committed to help pet owners protect their animals from parasites. Today we have taken an important next step to further deliver on this commitment to our customers." Dr. Sabine Bongaerts, Head of Drug Discovery within Bayer Animal Health, added: "This license agreement combines the strong science base within Bayer with innovative chemistry from MCAG. It will enable us to further expand our strong portfolio of parasiticides in the companion animal sector and deliver new compelling products to our customers." Mr. Satoshi Ozawa, President and CEO of MCAG said: "Under the concept of Technology and Innovation, MCAG has been providing its innovative products and services to the customers in agrochemicals and environmental health businesses for many years so far. Now, through close and successful collaboration with Bayer in the animal health sector, we are excited about this new opportunity to have our innovation work for another horizon of companion animal business." About Mitsui Chemicals Mitsui Chemicals (Tokyo: 4183, ISIN: JP3888300005), which traces its roots back to 1912, has an annual sale of 1,300 billion yen in the fiscal year ending March 2018 and more than 130 companies with over 17,000 employees in 28 countries. As one of Japan's leading chemical companies, Mitsui Chemicals contributes broadly to society by providing high-quality products and services to customers through innovations and creation of materials and products while keeping in harmony with the global environment. Its business portfolio includes materials for next-generation mobility, healthcare services, packaging, agrochemicals, electronic materials, and environment and energy sector. Mitsui Chemicals will continue to contribute to solving social challenges with its state-of-the-art technology and by "Creating New Customer Value through Innovation". Mitsui Chemicals' global agrochemical business is operated by its 100% subsidiary, Mitsui Chemicals Agro, Inc., who supplies innovative agrochemicals for crop protection and pest management. With a customer-centric point of view, The Company offers unique and effective products and services, and contributes to the sustainable, productive agriculture. Latest group news can be found at https://www.mitsuichem.com/en/. Tweet |
|
|
|
|
|
|
|
|
|||||||||||||
